Clasina M. Venema

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Serial [18F]-FDHT-PET to predict bicalutamide efficacy in patients with androgen receptor positive metastatic breast cancer.

Serial [18F]-FDHT-PET to predict bicalutamide efficacy in patients with androgen receptor positive metastatic breast cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 13, 2020

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imaging.

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imaging.

Journal: Breast cancer research : BCR

Published: March 31, 2020

Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study.

Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study.

Journal: EJNMMI research

Published: November 19, 2019

Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition.

Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 22, 2019

Enhanced pulmonary uptake on 18F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?

Enhanced pulmonary uptake on 18F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?

Journal: EJNMMI research

Published: April 23, 2019

Consideration of breast cancer subtype in targeting the androgen receptor.

Consideration of breast cancer subtype in targeting the androgen receptor.

Journal: Pharmacology & therapeutics

Published: September 11, 2018

18F-FES PET Has Added Value in Staging and Therapy Decision Making in Patients With Disseminated Lobular Breast Cancer.

18F-FES PET Has Added Value in Staging and Therapy Decision Making in Patients With Disseminated Lobular Breast Cancer.

Journal: Clinical nuclear medicine

Published: June 13, 2017

Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.

Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 29, 2017

Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience.

Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience.

Journal: Clinical nuclear medicine

Published: September 09, 2016

Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation.

Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 03, 2016

Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trial.

Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trial.

Journal: The British journal of dermatology

Published: July 09, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026